SANDOSTATIN

Google image searchProduct monograph

Active ingredient

octreotide (octreotide acetate), 50 MCG/ML

DIN: 00839191

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 15-APR-1998

ATC:

• H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
• H01C — HYPOTHALAMIC HORMONES (ATC, ATC/DDD)
• H01CB — Antigrowth hormones (ATC, ATC/DDD)
• H01CB02 — OCTREOTIDE (ATC/DDD)

Reference brand drug: Sandostatin

Pharmaceutical standard: MFR

External Links for Sandostatin

Search on Google

• Sandostatin side effects
• Sandostatin dosage
• octreotide side effects
• octreotide dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find sandostatin photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.